Reported Mar 2, 2022 · Ongoing
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising…
Rising Pharmaceuticals
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: RISING PHARMACEUTICALS · 2 Tower Center Blvd · East Brunswick, NJ · 08816-1100
Is this the product you have?
- Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only
- Manufactured forRising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
- Lot codes and dates
lot# 25910009Exp 01/2023
- Amount recalled
- 2220 100-count bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Rising Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.